Scottish water treatment tech business Scotmas has secured £2.2m in equity funding to support its international expansion plans.
The latest investment will help accelerate its growth, with an initial focus on establishing in-country sales, manufacturing and servicing capacity in the Middle East and South America.
The Kelso-based family-owned business employs 50 staff and the investment is set to create 40 new jobs over the next three years.
Scotmas’ core technology relates to the application of chlorine dioxide (ClO₂) as a method to control bacteria and other pathogens present in water and food contact surfaces across a variety of industries.
The group’s systems currently treat over two billion litres of water per day worldwide, including markets like New Zealand, Dubai and Chile.
The investment was led by the Investment Fund for Scotland (IFS), managed by Maven Capital Partners and delivered by the British Business Bank, alongside investment from Scottish Enterprise.
“We are delighted to have secured this significant investment led by Maven, which highlights the strength of our technology and reinforces our vision for the future of water disinfection,” said Alistair Cameron, Scotmas CEO.
“This funding represents a tremendous opportunity to scale our operations, drive innovation through research and development, and deliver sustainable, cost-effective water treatment solutions to a growing global market.”
Alan Robertson, partner at Maven, added: “Scotmas has grown to be the best-in-class provider of ClO₂ technology through years of R&D and academic partnerships.
“We’re delighted to back Alistair and the team at this point in the group’s growth journey as they embark on ambitious expansion plans to serve international markets.”
‘I’ll never forget Dragons’ Den star’s first words after investment’
